Assessing Drug Epetraborole in Patients with Mycobacterium avium Complex Lung Disease (MACrO2)

Brief description of study

The purpose of this study is to learn about the effects of a study drug, Epetraborole, to assess the efficacy for treating refractory MAC. It will enroll patients over 18 years of age and will include the following: physical exams, CTs, medical history, ECGs, lung function tests, vital signs, safety labs, PK labs, and questionnaires. Participants will be paid $50 for each study visit.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Medical Research, Mycobacterium avium Complex Lung Disease (MACrO2)
Age: Between 18 Years - 99 Years
Gender: All

Updated on 09 Mar 2024. Study ID: 851421

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).